Lepu Bio
About:
Lepu Bio is a Innovation-Driven Biopharmaceutical Company.
Website: https://en.lepubiopharma.com
Top Investors: Vivo Capital, Shanghai Biomedical Industrial Equity Investment Fund, SDIC Unity Capital, RiverHead Capital, Asset Management Association of China
Description:
Lepu Bio they have developed an oncology-focused pipeline of drug candidates, including ADCs, oncolytic virus drugs, and immunotherapies at clinical and pre-clinical stages.
Total Funding Amount:
$346M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2018-01-01
Founders:
Zhongjie Pu
Number of Employees:
251-500
Last Funding Date:
2024-05-17
IPO Status:
Public
© 2025 bioDAO.ai